You are here: All Products  > Chi-Med Starts China Phase II Trial of Surufatinib/Tuoyi Combo in Solid Tumors

Chi-Med Starts China Phase II Trial of Surufatinib/Tuoyi Combo in Solid Tumors

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products